In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis

Journal:
Science Translational Medicine
Published:
DOI:
10.1126/scitranslmed.ads0633
Affiliations:
11
Authors:
31
Go to article
Institutions Authors Share
Brain and Spine Institute (ICM), France
9.000000
 0.29
Vita-Salute San Raffaele University (UniSR), Italy
6.000000
 0.19
University Hospital of Münster (UKM), WWU, Germany
5.000000
 0.16
UCSF Health, United States of America (USA)
2.000000
 0.06
Montreal Neurological Institute and Hospital (MNI), McGill University, Canada
2.000000
 0.06
National Institute of Health (ISS), Italy
2.000000
 0.06
University of Milan (UNIMI), Italy
1.000000
 0.03
Institute of Genetic and Biomedical Research (IRGB), CNR, Italy
1.000000
 0.03
IRBM Science Park SpA, Italy
1.000000
 0.03
University Hospital Duesseldorf (UKD), Germany
1.000000
 0.03
University Medical Center Mainz, JGU, Germany
1.000000
 0.03
Interested in Neurosciences?